BridgeBio Oncology Shares Rise After FDA Fast-Tracks Pancreatic Cancer Treatment

Shares of BridgeBio Oncology Therapeutics are trading higher following news the U.S. Food and Drug Administration gave fast-track designation to a treatment for certain adult patients with pancreatic ...

BridgeBio Oncology Therapeutics stock jumps 10% on FDA nod

BridgeBio Oncology Therapeutics (NASDAQ:BBOT) shares rose 10% in after-hours trading Monday following the U.S. FDA’s Fast Track designation for BBO-11818 for th ...

Analysts Conflicted on These Healthcare Names: BridgeBio Oncology Therapeutics (BBOT), Sanofi (OtherSNYNF) and Molina Healthcare (MOH)

Detailed price information for Molina Healthcare Inc (MOH-N) from The Globe and Mail including charting and trades.
Seeking Alpha

BBOT BridgeBio Oncology Therapeutics, Inc.

BridgeBio Oncology Therapeutics, Inc., a clinical-stage biotechnology company, engages in the development of small-molecule therapeutics for the treatment of renin-angiotensin system and ...